These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7268361)

  • 1. [Diagnosis and therapy of hormonally active cancer of the adrenal cortex. Study of 5 cases].
    Tenschert W; Vetter H; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1981 Jul; 111(29):1080-8. PubMed ID: 7268361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocortical carcinoma. Our experience.
    Favia G; Lumachi F; Carraro P; D'Amico DF
    Minerva Endocrinol; 1995 Mar; 20(1):95-9. PubMed ID: 7651289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocortical tumors in children.
    Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
    J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of MMP-1, MMP-8, MMP-9 serum levels in patients with adrenal tumors prior to and after surgery.
    Kołomecki K; Stepień H; Bartos M; Narebski J
    Neoplasma; 2001; 48(2):116-21. PubMed ID: 11478691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia.
    Storr HL; Mitchell H; Swords FM; Main KM; Hindmarsh PC; Betts PR; Shaw NJ; Johnston DI; Clark AJ; Reznek RH; Grossman AB; Savage MO
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):553-9. PubMed ID: 15521956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapidly progressing high o,p'DDD doses shorten the time required to reach the therapeutic threshold with an acceptable tolerance: preliminary results.
    Faggiano A; Leboulleux S; Young J; Schlumberger M; Baudin E
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):110-3. PubMed ID: 16402938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortisol as a possible marker of metastatic adrenocortical carcinoma: a case report with 3-year follow-up.
    Schwarte S; Brabant EG; Bastian L; Bruns F
    Anticancer Res; 2007; 27(4A):1917-20. PubMed ID: 17649795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical interventions of the adrenal gland. Diagnosis and results of treatment].
    Hofmockel G; Heimbach D; Bussen D; Reincke M; Frohmüller HG
    Urologe A; 1994 Nov; 33(6):505-11. PubMed ID: 7817448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenocortical carcinoma: epidemiology and natural history.
    Boscaro M; Fallo F; Barzon L; Daniele O; Sonino N
    Minerva Endocrinol; 1995 Mar; 20(1):89-94. PubMed ID: 7651287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases.
    Luton JP; Mahoudeau JA; Bouchard P; Thieblot P; Hautecouverture M; Simon D; Laudat MH; Touitou Y; Bricaire H
    N Engl J Med; 1979 Mar; 300(9):459-64. PubMed ID: 215912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinoma of the adrenal cortex].
    Hamborg B; Frey H; Bøhmer T; Norman N
    Tidsskr Nor Laegeforen; 1990 Mar; 110(8):956-9. PubMed ID: 2321225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adrenocortical carcinoma].
    Gur C; Salmon A; Silvetski N; Gross DJ
    Harefuah; 2008 Jun; 147(6):520-5, 574. PubMed ID: 18693629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy.
    Luton JP; Cerdas S; Billaud L; Thomas G; Guilhaume B; Bertagna X; Laudat MH; Louvel A; Chapuis Y; Blondeau P
    N Engl J Med; 1990 Apr; 322(17):1195-201. PubMed ID: 2325710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of concurrent bilateral adrenocortical adenoma causing Cushing's syndrome].
    Koga F; Sumi S; Umeda H; Maeda S; Honda M; Hosoya Y; Yano M; Konita A; Suzuki S; Yoshida K
    Hinyokika Kiyo; 1997 Apr; 43(4):275-8. PubMed ID: 9161855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Practical use of o,p'DDD in adrenocortical carcinoma].
    Bacchetta J; Droz JP
    Bull Cancer; 2005 Mar; 92(3):273-9. PubMed ID: 15820922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subclinical Cushing's syndrome:analysis of diagnosis and surgical effect].
    Feng C; Li HZ; Xiao H; Yan WG; Li YQ; Xu WF
    Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1691-3. PubMed ID: 18476528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients.
    Abdelhamid S; Müller-Lobeck H; Pahl S; Remberger K; Bönhof JA; Walb D; Röckel A
    Arch Intern Med; 1996 Jun; 156(11):1190-5. PubMed ID: 8639013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes analysis in patients undergoing laparoscopic adrenalectomy for hormonally active adrenal tumors.
    Brunt LM; Moley JF; Doherty GM; Lairmore TC; DeBenedetti MK; Quasebarth MA
    Surgery; 2001 Oct; 130(4):629-34; discussion 634-5. PubMed ID: 11602893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of o,p'-DDD on human adrenal steroid synthesis].
    Ojima M; Saito M; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1984 Jul; 60(7):852-71. PubMed ID: 6094274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.